These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24588559)

  • 1. Cannabinoids: clearing the smoke on pain, inflammation and neurodegeneration.
    Downer EJ; Finn DP
    Br J Pharmacol; 2014 Mar; 171(6):1341-4. PubMed ID: 24588559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cannabinoids on generic traits of neurodegeneration.
    Fagan SG; Campbell VA
    Br J Pharmacol; 2014 Mar; 171(6):1347-60. PubMed ID: 24172185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.
    Fernández-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1370-1383. PubMed ID: 29856067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. So what do we call GPR18 now?
    Alexander SP
    Br J Pharmacol; 2012 Apr; 165(8):2411-3. PubMed ID: 22014123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.
    Moreno-Sanz G; Sasso O; Guijarro A; Oluyemi O; Bertorelli R; Reggiani A; Piomelli D
    Br J Pharmacol; 2012 Dec; 167(8):1620-8. PubMed ID: 22774772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and their actions: An update.
    Alexander SPH; Molina-Holgado F
    Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint problems arising from lack of repair mechanisms: can cannabinoids help?
    Malek N; Starowicz K
    Br J Pharmacol; 2019 May; 176(10):1412-1420. PubMed ID: 29574720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.
    Alhamoruni A; Wright KL; Larvin M; O'Sullivan SE
    Br J Pharmacol; 2012 Apr; 165(8):2598-610. PubMed ID: 21745190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids in pain and inflammation.
    Mbvundula EC; Rainsford KD; Bunning RA
    Inflammopharmacology; 2004; 12(2):99-114. PubMed ID: 15265314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glial cannabinoid CB
    Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the CB
    Rodríguez-Cueto C; García-Toscano L; Santos-García I; Gómez-Almería M; Gonzalo-Consuegra C; Espejo-Porras F; Fernández-Ruiz J; de Lago E
    Br J Pharmacol; 2021 Mar; 178(6):1373-1387. PubMed ID: 33486755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases.
    Arribas RL; Romero A; Egea J; de Los Ríos C
    Br J Pharmacol; 2018 Aug; 175(16):3220-3229. PubMed ID: 29781146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and neuroinflammation.
    Walter L; Stella N
    Br J Pharmacol; 2004 Mar; 141(5):775-85. PubMed ID: 14757702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic cannabis use in 2018: where do we stand?
    Hill KP; Palastro MD; George TP
    Lancet Psychiatry; 2019 Feb; 6(2):88-89. PubMed ID: 30686389
    [No Abstract]   [Full Text] [Related]  

  • 16. Themed section: endothelin.
    Davenport AP; Barton M
    Br J Pharmacol; 2013 Jan; 168(2):279-82. PubMed ID: 23278331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.
    Abeti R; Zeitlberger A; Peelo C; Fassihi H; Sarkany RPE; Lehmann AR; Giunti P
    Br J Pharmacol; 2019 Nov; 176(22):4293-4301. PubMed ID: 30499105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
    Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
    Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids:their role in pain and palliation.
    McCarberg BH
    J Pain Palliat Care Pharmacother; 2007; 21(3):19-28. PubMed ID: 18032352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of cannabis.
    de Vries K; Green AJ
    Nurs Times; 2012 Feb 28-Mar 5; 108(9):12-5. PubMed ID: 22479766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.